About Unnati Pharmaceutical
Unnati Pharmaceutical is a Healthcare company based in Mumbai (India) founded in 2003. It serves as a supplier of APIs, enzymes, nutraceuticals, pellets, excipients, and related products. It operates on a B2B model. Its Indian entity Unnati Pharmaceuticals Private Limited reported revenue of ₹155 Cr. Its focus areas include Pharmaceuticals, Supply Chain and Product Distribution. Its competitors include Entero Healthcare and Take Solutions; 1 of its 2 listed competitors has raised funding.
Company details
Unnati Pharmaceutical serves as a supplier of apis, enzymes, nutraceuticals, pellets, excipients, and related products through providing healthcare solutions, producing pharmaceutical products, optimizing supply chain operations, and product distribution. Prioritizing client-centric approaches, it ensures high-quality outcomes, innovation, and sustainable practices in its field.
- Headquarters Mumbai, India
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website unnatipharmaceuticals.com
- Legal Name Unnati Pharmaceuticals Private Limited
- Date of Incorporation 24 Jun, 2003
- Jurisdiction Mumbai, Maharashtra, India
- Annual Revenue₹155 Cr
FY 2023 · -3% YoY
- Net Profit₹47 Lakh
FY 2023 · 0% margin
- EBITDA₹1.25 Cr
FY 2023 · 1% margin
Associated legal entities of Unnati Pharmaceutical
Unnati Pharmaceutical is associated with 2 registered companies on The Company Check; the primary company is Unnati Pharmaceuticals Private Limited. Each company page carries the filings, financials, charges and directors of that entity.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2023) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Unnati Pharmaceuticals Private Limited CIN U24231MH2003PTC428884 | Active | 24 Jun 2003 | Mumbai, Maharashtra | ₹155 Cr | 2 | View details | |
| Jagvan Tradelink Private Limited CIN U74900WB2013PTC196866 | Active | 30 Aug 2013 | Chanditala, West Bengal | ₹271 Cr | 2 | View details |
Board of directors of Unnati Pharmaceuticals Private Limited (Unnati Pharmaceutical)
Unnati Pharmaceuticals Private Limited is the primary company behind Unnati Pharmaceutical. The boards of the 2 registered companies of Unnati Pharmaceutical currently have 4 directors; the longest-serving is Hetal Bhupatrai Mehta, appointed in 2010. 11 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Hetal Bhupatrai Mehta DIN 00411984 | Director | 30 Jun 2010 | 16 yrs 4 mo | Unnati Pharmaceuticals Private Limited |
| Santanu Poddar DIN 07472320 | Director | 31 Mar 2016 | 10 yrs 7 mo | Jagvan Tradelink Private Limited |
| Naishil Hetal Mehta DIN 07686570 | Director | 21 Dec 2016 | 9 yrs 10 mo | Unnati Pharmaceuticals Private Limited |
| Partha Halder DIN 07514959 | Director | 31 Jul 2024 | 2 yrs 3 mo | Jagvan Tradelink Private Limited |
Financials of Unnati Pharmaceutical
Figures of Unnati Pharmaceuticals Private Limited, the primary company behind Unnati Pharmaceutical, for FY 2023. Revenue was ₹155 Cr (-3% year on year). Net profit was ₹47 Lakh (0% margin). EBITDA was ₹1.25 Cr (1% margin). Revenue has grown at a compounded annual rate of +13% over three years and +14% over five years.
- ₹155 CrRevenue · FY 2023 · -3% YoY
- ₹47 LakhNet profit · 0% margin
- ₹1.25 CrEBITDA · 1% margin
- ₹9 LakhPaid-up capital
- +13%Revenue CAGR, 3 years
- +14%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Unnati Pharmaceuticals Private Limited are on its company page.
Detailed financial statements for Unnati Pharmaceutical
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Competitors of Unnati Pharmaceutical
Unnati Pharmaceutical has 2 listed competitors in our database, 1 of them funded. They include Entero Healthcare and Take Solutions.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| enterohealthcare.com | 2018 | Mumbai, India | $59.67M | 817 | India's leading healthcare products distribution platform | |
| takesolutions.com | 2000 | Chennai, India | 5 | Life sciences and supply chain management services are provided. |
Detailed competitors of Unnati Pharmaceutical
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Unnati Pharmaceutical
Unnati Pharmaceutical was founded in 2003.
Unnati Pharmaceutical is headquartered in Mumbai, India. It is registered at Mumbai, Maharashtra, India.
The primary company behind Unnati Pharmaceutical, Unnati Pharmaceuticals Private Limited, reported revenue of ₹155 Cr for FY 2023, down 3% year on year.
Unnati Pharmaceutical serves as a supplier of apis, enzymes, nutraceuticals, pellets, excipients, and related products through providing healthcare solutions, producing pharmaceutical products, optimizing supply chain operations, and product distribution. Prioritizing client-centric approaches, it ensures high-quality outcomes, innovation, and sustainable practices in its field.
Unnati Pharmaceutical's top competitors include Entero Healthcare and Take Solutions.
Unnati Pharmaceutical is associated with 2 legal entities: Unnati Pharmaceuticals Private Limited, Jagvan Tradelink Private Limited.
The legal entities of Unnati Pharmaceutical currently have 4 directors, including Naishil Hetal Mehta, Hetal Bhupatrai Mehta, Santanu Poddar and others.